Unlike other commonly used drugs such as metformin or GLP‐1, which acutely improve glucose control in diabetes, MI treatment epigenetically regulates the menin/JunD/Pbk axis, therefore taking a relatively longer time to increase beta cell mass and improve glucose control in diabetes. Here, PBK is linked to diabetes mellitus.